Delivery Order SPE2DB22D3004-SPE2DB24FNE10
- Not listed
- This federal contract award is for the delivery of Dorzolamide-Timolol eye drops, 10 mL, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,463.60 and is a Firm Fixed Price Delivery Order. It has an ultimate completion date of March 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Dorzolamide-Timolol eye drops. The Delivery Order contract, valued at $13,590.31, has a Firm Fixed Price pricing type and an ultimate completion date of October 19, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of DORZOLAMIDE-TIMOLOL EYE DROPS 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a contract ceiling value of $3,484.43 and an ultimate completion date of December 2, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside used. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Dorzolamide-Timolol 2%-0.5% eye drops, a glaucoma medication, to the Defense Logistics Agency (DLA). The $1,853.77 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 27, 2025 with a completion date of May 28, 2025. The award is not a set-aside contract. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award, valued at $1,772.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4564260040 - Dorzolamide-Timolol Eye Drops 10ML, a pharmaceutical product, with a performance period through April 15, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,932.85 firm fixed-price delivery order is for the supply of 10 ml bottles of dorzolamide-timolol eye drops. The contract has an ultimate completion date of June 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,594.28 firm fixed-price delivery order is for the provision of 4565243277 - Dorzolamide-Timolol eye drops, 10 mL. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,293.36 Delivery Order contract is for the supply of Dorzolamide-Timolol Eye Drops 10ML. The contract is a Firm Fixed Price arrangement with a period of performance through March 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of Dorzolamide HCL 2% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $2,570.95. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 11, 2024. The award was made on January 10, 2024, and there was no set-aside designation used. Amerisourcebergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dorzolamide-Timolol eye drops. The contract has a ceiling value of $3,019.42 and a completion date of May 22, 2025. The contract is a firm fixed-price, non-set-aside vehicle, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FNE10Delivery Order
This federal contract award is for the delivery of Dorzolamide-Timolol Eye Drops 10ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $3,587.53 and an Ultimate Completion Date of October 17, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 10/16/23 |